Medical Edge

Researchers develop device to detect brain tumour through urine
Medical Edge

Researchers develop device to detect brain tumour through urine

A team of researchers in Japan have developed a new device to identify a key membrane protein in the urine that indicates if the patient has a brain tumour. Tokyo, Feb 3 : A team of researchers in Japan have developed a new device to identify a key membrane protein in the urine that indicates if the patient has a brain tumour. A research group led by Associate Professor Takao Yasui and Professor Yoshinobu Baba of Japan-based Nagoya University in collaboration with the University of Tokyo has developed a new analysis platform for brain tumour EVs using nanowires at the bottom of a well plate. They used this device to identify two types of extracellular vesicle (EV) membrane proteins known as CD31 and CD63 in urine samples from brain tumour patients. Doctors may be able to id...
Experts uphold universal HPV vaccination to save women from cervical cancer
Medical Edge

Experts uphold universal HPV vaccination to save women from cervical cancer

Globally, 27 per cent of cervical cancer cases are from India which is home to 16-17 per cent of the world's women population. The current estimates indicate approximately 1,00,000 new cases diagnosed and 60,000 deaths annually in India, accounting for nearly a third of the global cervical cancer deaths. New Delhi, Jan 29 : Globally, 27 per cent of cervical cancer cases are from India which is home to 16-17 per cent of the world's women population. The current estimates indicate approximately 1,00,000 new cases diagnosed and 60,000 deaths annually in India, accounting for nearly a third of the global cervical cancer deaths. Over the past 40 years mortality from carcinoma of the cervix has fallen due to improved treatment and the introduction of national screening programmes. ...
Young scientist develops biosensor that can detect Covid from sweat
Medical Edge

Young scientist develops biosensor that can detect Covid from sweat

A former student of the Allahabad University (AU) claims to have developed a biosensor that can detect Covid-19 infection through sweat samples. Prayagraj (Uttar Pradesh), Jan 31 : A former student of the Allahabad University (AU) claims to have developed a biosensor that can detect Covid-19 infection through sweat samples. Amit Dubey, 34, who is working as a senior scientist at Quanta Calculus, Greater Noida, claims that he has developed the world's first specific, reliable ultra-small gold nanoclusters for biomedical and biosensing applications to detect Covid. His work can lead to a new age of effective and cheaper testing kits capable of detecting Covid-19 using just the sweat of an individual instead of nasal or throat swabs that kits of today need. Sharing his rese...
Researchers working on Covid vaccine that people can drink
Medical Edge

Researchers working on Covid vaccine that people can drink

Researchers are working on a Covid-19 vaccine that people may drink instead of receiving with a needle, expanding their focus onto mucosal vaccines, which include nasal vaccines as well as "swish and swallow" oral vaccines. San Francisco, Jan 23 : Researchers are working on a Covid-19 vaccine that people may drink instead of receiving with a needle, expanding their focus onto mucosal vaccines, which include nasal vaccines as well as "swish and swallow" oral vaccines. The vaccine, called QYNDR, completed its phase 1 clinical trial and is currently waiting on more funding to conduct the more detailed, advanced trials that could actually bring the vaccine to market, reports CNET. "The QYNDR vaccine is pronounced 'kinder', because it's a softer way to deliver a vaccine," Kyle F...
US researchers eye developing mucosal vaccines for respiratory viruses
Medical Edge

US researchers eye developing mucosal vaccines for respiratory viruses

US researchers are exploring the challenges and outlining approaches to develop mucosal vaccines for respiratory viruses, according to a statement of the US National Institute of Health (NIH). Los Angeles, Jan 12 : US researchers are exploring the challenges and outlining approaches to develop mucosal vaccines for respiratory viruses, according to a statement of the US National Institute of Health (NIH). Vaccines that provide long-lasting protection against influenza, coronaviruses and respiratory syncytial virus (RSV) have proved exceptionally difficult to develop, said the NIH on Wednesday. Flu, RSV, SARS-CoV-2 and "common cold" coronaviruses share several characteristics that enable them to cause repeated re-infections, including very short incubation periods, rapid host...
Finnish researchers develop new genetic test to improve ovarian cancer treatment
Medical Edge

Finnish researchers develop new genetic test to improve ovarian cancer treatment

A new genetic test developed at the University of Helsinki and Helsinki University Hospital helps identify ovarian cancer patients who benefit from PARP inhibitors, a type of targeted drug that could be effective against ovarian cancer, the University of Helsinki said in a statement. Helsinki, Jan 12 : A new genetic test developed at the University of Helsinki and Helsinki University Hospital helps identify ovarian cancer patients who benefit from PARP inhibitors, a type of targeted drug that could be effective against ovarian cancer, the University of Helsinki said in a statement. In recent years, PARP inhibitors have achieved excellent results as a maintenance treatment after surgery and cytostatic therapy of newly diagnosed ovarian cancer patients. Since the therapy with...
Researchers tests AI tool that predicts risk of lung cancer
Medical Edge

Researchers tests AI tool that predicts risk of lung cancer

With lung cancer the leading cause of cancer death around the world, researchers have tested an AI tool known as "Sybil" that accurately predicts its risk for individuals with or without a significant smoking history, a new study has shown. San Francisco, Jan 13 : With lung cancer the leading cause of cancer death around the world, researchers have tested an AI tool known as "Sybil" that accurately predicts its risk for individuals with or without a significant smoking history, a new study has shown. Based on analyses of LDCT (low-dose chest computed tomography) scans from patients in the US and Taiwan, Sybil accurately predicted the risk of lung cancer for individuals with or without a significant smoking history, according to the study published in the Journal of Clinical On...
BioAsia 2023 to focus on opportunities in life science post-Covid
Medical Edge

BioAsia 2023 to focus on opportunities in life science post-Covid

BioAsia 2023, Asia's largest life-sciences and healthcare forum, scheduled to be held next month, will discuss the learnings, challenges and opportunities in life science post-Covid-19, organisers said. Hyderabad, Jan 10 : BioAsia 2023, Asia's largest life-sciences and healthcare forum, scheduled to be held next month, will discuss the learnings, challenges and opportunities in life science post-Covid-19, organisers said. The 20th edition of BioAsia - the marquee healthcare and life sciences event, organized by the Telangana government, will feature prominent government dignitaries, industry leaders, researchers, entrepreneurs, and other delegates, and explore the theme of Advancing for ONE: Shaping the next generation of humanized healthcare. The event is scheduled to be h...
Gut bacteria linked with high death risk in Covid patients: Indian-origin scientist
Medical Edge

Gut bacteria linked with high death risk in Covid patients: Indian-origin scientist

A new study, led by an Indian-American researcher, has found differences in gut bacteria and metabolites among Covid-19 patients admitted in the ICU, offering possibilities for preventing future deaths. New York, Jan 10 : A new study, led by an Indian-American researcher, has found differences in gut bacteria and metabolites among Covid-19 patients admitted in the ICU, offering possibilities for preventing future deaths. According to Bhakti Patel, a pulmonary and critical care specialist at the University of Chicago Medicine, differences in gut microbiome are linked to increase in risk of death in Covid-19 patients with respiratory failure. The findings could open a window for giving patients probiotic treatments containing the right strains of bacteria to produce protectiv...
Does Covid change body’s response to other threats? Your gender decides
Medical Edge

Does Covid change body’s response to other threats? Your gender decides

The emergence of the Covid-19 pandemic in 2020 allowed researchers to test the theory -- does Covid changes the body's response to other threats, and the answer they found was that it "depends on the individual's gender". San Francisco, Jan 5 : The emergence of the Covid-19 pandemic in 2020 allowed researchers to test the theory -- does Covid changes the body's response to other threats, and the answer they found was that it "depends on the individual's gender". John Tsang, a professor of immunobiology and biomedical engineering at Yale University, has long believed that the immune system reverts to the previous stable baseline after viral infection. According to a study published in the journal Nature, a team led by Tsang systematically analysed the immune responses of hea...